Robin Garner
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
4
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robin Garner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $3.22 | +39.75% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $1.49 | +1,644.97% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | $17 | $4.65 | +265.59% | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.22
Upside: +39.75%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $1.49
Upside: +1,644.97%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $4.65
Upside: +265.59%